Investigation of an edible TCM bitter melon (Momordica charantia): metabolite profiling, differentiation and characterization

被引：2
作者：
Zhou, S. [1 ,2 ,3 ,5 ]
Ye, Y. [1 ,2 ,3 ]
Afzan, A. [5 ]
Allard, P. M. [5 ]
Wolfrum, C. [4 ]
Wolfender, J. L. [5 ]
机构：
[1] Chinese Acad Sci, Nat Prod Chem Dept, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd,Zhangjiang High Teck Pk, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd,Zhangjiang High Teck Pk, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, SIMM CUHK Joint Res Lab Promoting Tradit Chinese, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd,Zhangjiang High Teck Pk, Shanghai 201203, Peoples R China
[4] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schorenstr 16, CH-8603 Schwerzenbach, Switzerland
[5] Univ Lausanne, Sch Pharmaceut Sci, EPGL, Univ Geneva, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland
来源：
PLANTA MEDICA | 2016年 / 82卷
关键词：
Metabolomics; bitter melon; Momordica charantia; PCA; UHPLC-TOF MS; triterpenoids; molecular networking;
D O I：
10.1055/s-0036-1596193
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
P21
引用
收藏
页数：2
相关论文
共 50 条
  • [41] First Report of Zucchini Yellow Mosaic Virus Infecting Bitter Melon (Momordica charantia) in South Korea
    Lee, Hyo-Jeong
    Cho, In-Sook
    Jeong, Rae-Dong
    PLANT DISEASE, 2022, 106 (11)
  • [42] Activating Effect of Momordin, Extract of Bitter Melon (Momordica Charantia L.), on the Promoter of Human PPARδ
    Sasa, Masatoshi
    Inoue, Ikuo
    Shinoda, Yuichi
    Takahashi, Seiichiro
    Seo, Makoto
    Komoda, Tsugikazu
    Awata, Takuya
    Katayama, Shigehiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (06) : 888 - 892
  • [43] Effects of 1-MCP on postharvest physiology and quality of bitter melon (Momordica charantia L.)
    Han, Cong
    Zuo, Jinhua
    Wang, Qing
    Xu, Lijing
    Wang, Zhaosheng
    Dong, Haizhou
    Gao, Lipu
    SCIENTIA HORTICULTURAE, 2015, 182 : 86 - 91
  • [44] Characterization of antioxidant polysaccharides in bitter gourd (Momordica charantia L.) cultivars
    Li, Junli
    Wang, Yunqiang
    Huang, Jin
    Xu, Xiaofei
    Xiang, Changping
    JOURNAL OF FOOD AGRICULTURE & ENVIRONMENT, 2010, 8 (3-4): : 117 - 120
  • [45] The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial
    May, Lim Soo
    Sanip, Zulkefli
    Shokri, Amran Ahmed
    Kadir, Azidah Abdul
    Lazin, Md Rizman Md
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2018, 32 : 181 - 186
  • [46] Pharmacognostic Evaluation of Bitter Melon from Brazilian Northeast (Momordica charantia L.): Identification of Momordicin II
    Sagastegui Guarniz, William Antonio
    Rocha Valadas, Lidia Audrey
    Silva, Karine Lima
    Magalhaes, Karla Nascimento
    Braz Filho, Raimundo
    Garcia do Nascimento, Patricia Georgina
    Monteiro, Mirian Parente
    Medeiros Bandeira, Mary Anne
    JOURNAL OF YOUNG PHARMACISTS, 2019, 11 (04) : 366 - 370
  • [47] Mechanism(s) of liver triglyceride-lowering action of dietary bitter melon (Momordica charantia) extracts in the rat
    Iwamoto, M.
    Ohta, H.
    Nishizono, S.
    Senanayake, G. Vk
    Fukuda, N.
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 : 168 - 168
  • [48] Bitter melon (Momordica charantia) extract suppresses cytokineinduced activation of MAPK and NF-κB in pancreatic β-Cells
    Kyong Kim
    Hye Young Kim
    Food Science and Biotechnology, 2011, 20 : 531 - 535
  • [49] Evaluation of ultrasound pretreatment and drying methods on selected quality attributes of bitter melon (Momordica charantia L.)
    Jin, Wei
    Zhang, Min
    Shi, Weifeng
    DRYING TECHNOLOGY, 2019, 37 (03) : 387 - 396
  • [50] Bio-active compounds of bitter melon genotypes (Momordica charantia L.) in relation to their physiological functions
    Islam, Shahidul
    Jalaluddin, Mohammad
    Hettiarachchy, Navam S.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2011, 1 (02): : 61 - 74
12345